BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10194621)

  • 1. Statistical methods for the analysis of cancer survival data.
    Black RJ; Swaminathan R
    IARC Sci Publ; 1998; (145):3-7. PubMed ID: 10194621
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpretation of population-based cancer survival data.
    Black RJ; Sankaranarayanan R; Parkin DM
    IARC Sci Publ; 1998; (145):13-7. PubMed ID: 10194623
    [No Abstract]   [Full Text] [Related]  

  • 3. Providing more up-to-date estimates of patient survival: a comparison of standard survival analysis with period analysis using life-table methods and proportional hazards models.
    Smith LK; Lambert PC; Botha JL; Jones DR
    J Clin Epidemiol; 2004 Jan; 57(1):14-20. PubMed ID: 15019006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer registration: principles and methods. Analysis of survival.
    Parkin DM; Hakulinen T
    IARC Sci Publ; 1991; (95):159-76. PubMed ID: 1894319
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries.
    Gondos A; Bray F; Brewster DH; Coebergh JW; Hakulinen T; Janssen-Heijnen ML; Kurtinaitis J; Brenner H;
    Eur J Cancer; 2008 Jul; 44(10):1463-75. PubMed ID: 18455387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-to-date and precise estimates of cancer patient survival: model-based period analysis.
    Brenner H; Hakulinen T
    Am J Epidemiol; 2006 Oct; 164(7):689-96. PubMed ID: 16840519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Unfamiliar with such high survival rates in tumors. Are we doing everything wrong here?].
    Holzgreve H
    MMW Fortschr Med; 2003 Feb; 145(7):24. PubMed ID: 12652821
    [No Abstract]   [Full Text] [Related]  

  • 8. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases.
    Brenner H; Rachet B
    Eur J Cancer; 2004 Nov; 40(16):2494-501. PubMed ID: 15519525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building a database for survival analysis.
    Guzzinati S; Vitarelli S; Ramazzotti V; Tumino R
    Epidemiol Prev; 2001; 25(3 Suppl):15-20. PubMed ID: 11695195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mortality studies in underwriting malignancies.
    Kay BR; Witte DL
    J Insur Med; 1991; 23(3):185-8. PubMed ID: 10148502
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attributing death to cancer: cause-specific survival estimation.
    Mathew A; Pandey M
    J Postgrad Med; 2002; 48(4):322-6. PubMed ID: 12571396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAERS: an application for Web-assisted estimation of relative survival.
    Clèries R; Valls J; Esteban L; Gálvez J; Pareja L; Sanz X; Alliste L; Martínez JM; Moreno V; Bosch X; Borràs JM; Ribes JM
    Med Inform Internet Med; 2007 Sep; 32(3):169-75. PubMed ID: 17701823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival chances of Hungarian cancer patients in the National Cancer Registry].
    Tusnády G; Gaudi I; Rejto L; Kásler M; Szentirmay Z
    Magy Onkol; 2008 Dec; 52(4):339-49. PubMed ID: 19068461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
    Bossard N; Velten M; Remontet L; Belot A; Maarouf N; Bouvier AM; Guizard AV; Tretarre B; Launoy G; Colonna M; Danzon A; Molinie F; Troussard X; Bourdon-Raverdy N; Carli PM; Jaffré A; Bessaguet C; Sauleau E; Schvartz C; Arveux P; Maynadié M; Grosclaude P; Estève J; Faivre J
    Eur J Cancer; 2007 Jan; 43(1):149-60. PubMed ID: 17084622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Database on cancer survival from developing countries.
    Swaminathan R; Black RJ; Sankaranarayanan R
    IARC Sci Publ; 1998; (145):19-25. PubMed ID: 10194624
    [No Abstract]   [Full Text] [Related]  

  • 17. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis.
    De Angelis R; Francisci S; Baili P; Marchesi F; Roazzi P; Belot A; Crocetti E; Pury P; Knijn A; Coleman M; Capocaccia R;
    Eur J Cancer; 2009 Apr; 45(6):909-30. PubMed ID: 19128955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Period estimates of cancer patient survival are more up-to-date than complete estimates even at comparable levels of precision.
    Brenner H; Hakulinen T
    J Clin Epidemiol; 2006 Jun; 59(6):570-5. PubMed ID: 16713519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risk of cancer in the Netherlands].
    Kiemeney LA; Lemmers FA; Verhoeven RH; Aben KK; Honing C; de Nooijer J; Peeters PH; Visser O; Vlems FA
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2233-41. PubMed ID: 19009811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry.
    Ellison LF; Pogany L; Mery LS
    Eur J Cancer; 2007 Sep; 43(13):1967-75. PubMed ID: 17616390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.